PYXS
Pyxis Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.33
−2.35%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 22.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 24.28x
- Price / sales
- 25.16x
- Price / cash flow
- -4.09x
Enterprise value
- Enterprise value
- $262.6M
- EV / sales
- 23.79x
- EV / EBITDA
- -3.15x
- EV / EBIT
- -2.85x
- Market cap
- $277.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026